Back to Markets
HRHeron Therapeutics Inc

Heron Therapeutics Inc

HRTXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$0.8701

-0.021800 (-2.44%)

As of 05/29/26 EDT · USD

Compare
Low: $0.7400Current: $0.8701High: $2.30

Key Statistics

Open

$0.8730

Day High

$0.8900

Day Low

$0.8501

Prev. Close

$0.8919

VolumeShares traded today.

1.76M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$164.69M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-5.00

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$2.30

52W LowLowest price over the past 52 weeks.

$0.7400

50D MAAverage closing price over the last 50 trading days.

$0.9508

200D MAAverage closing price over the last 200 trading days.

$1.17

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-0.1%

1M

-26.9%

6M

-20.2%

YTD

-30.9%

1Y

-54.9%

About

Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.

www.herontx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade HRTX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.